Press Releases
2010-07-22 Maywufa Biopharma Group: Applauded by President Ma
2010-04-20 PhytoHealth PG2 Approved By Taiwan FDA Nation’s First Botanical New Drug
2009-02-18 PhytoHealth Awarded the National Innovation Award
2009-02-05 PhytoHealth Completes Patient Enrollment in Phase II Clinical Trial of PHN081 (PDC-748), an antitussive new drug candidate.
2009-01-05 PhytoHealth Won the National Biotechnology Award.
2008-11-27 Maywufa Biopharma Group granted the Certificates of Taiwan Intellectual Property Management System (TIPS)
2008-11-11 PhytoHealth awarded the Taiwan Healthcare Industry Innovation and Excellence Awards 2008.
2008-09-10 Maywufa Biopharma Group Invests in Stem Cell Technology
2008-09-09 PhytoHealth Begins Bioavailability / Pharmacokinetic Study of PHN021 (PCNH), a New Chemical Entity for the Prevention of Motion Sickness without Causing Drowsiness
2008-07-16 PhytoHealth became the first new drug development company listed on Taiwan Stock Exchange (TWSE).
 
Next >  
 
  Privacy Policy - Terms of Use - Site Map